Aug 29, 2024 · Learn more about NIDA’s research on the health effects and therapeutic potential of psychedelic and dissociative drugs.

Jan 24, 2024 · Two dissociative drugs are currently FDA-approved: ketamine, which is approved as an anesthetic, and its derivative, esketamine, for treatment resistant depression. Scientists are …

NIDA's mission is to advance science on the causes and consequences of drug use and addiction and to apply that knowledge to improve individual and public health. NIDA is one of the National Institutes …

Apr 19, 2024 · MDMA, also called Molly or Ecstasy, is a lab-made (synthetic) drug that has effects similar to stimulants like methamphetamine, although some researchers and organizations consider …

5 days ago · Harnessing the brain’s natural plasticity in effecting therapeutic gains is an intuitively obvious avenue for drug development including the development of psychedelics as therapeutics, …

Apr 10, 2025 · Community misused or used drugs chart in an A to Z listing. Basic information on drugs with addictive potential, including how they are used, how they make people feel, and their health …

Jan 24, 2024 · Learn more about NIDA research on the therapeutic potential of psychedelic and dissociative drugs, including psilocybin. Along with other partners at the National Institutes of Health, …

Feb 6, 2024 · Law enforcement seizures of “magic mushrooms” or “shrooms” containing the psychoactive component psilocybin increased dramatically in the United States between January …

Apr 9, 2024 · For statistics on ketamine use, see the National Survey on Drug Use and Health from the Substance Abuse and Mental Health Services Administration. More information on ketamine use is …

Nov 20, 2024 · Explore data on methamphetamine use in the National Survey on Drug Use and Health from the Substance Abuse and Mental Health Services Administration (SAMHSA). For recent data …